# OnCo record parexel (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/parexel/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "parexel" ;
  schema:name "Parexel"@en ;
  schema:description "Parexel, of Durham, North Carolina, is a global contract research organisation owned by EQT and Goldman Sachs that runs early and late-phase oncology trials and sells regulatory consulting staffed by former FDA officials. Whether regulators moving into consulting sharpens trial design or blurs the line between regulator and industry is the question its model raises."@en ;
  schema:url <https://onco.cc/companies/parexel/>, <https://www.parexel.com> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://www.parexel.com> ;
  onco:tag "supporting" ;
  schema:addressCountry "US" ;
  onco:sections <https://onco.cc/fronts/ai-computation/> ;
  onco:technologies <https://onco.cc/technologies/contract-research-organisations/> ;
  onco:trials <https://onco.cc/trials/nct05943106/>, <https://onco.cc/trials/nct07069712/>, <https://onco.cc/trials/nct05629234/>, <https://onco.cc/trials/nct04452955/> .
